Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report

Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report

BackgroundImmune checkpoint inhibitors (ICIs) such as pembrolizumab and nivolumab are recommended as first-line therapies for recurrent and metastatic head and neck squamous cell carcinoma (HNSCC). However, their efficacy in neoadjuvant therapy remains uncertain.Case presentationWe report the case o...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying Sun, Guanghui Yang, Ruijie Sun, Fangli Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant
immunotherapy
chemotherapy
head and neck squamous cell carcinoma
major pathological response
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1462993/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items